Download PDF
Dtsch Med Wochenschr 2007; 132(25/26): 1392-1395
DOI: 10.1055/s-2007-982041
Klinischer Fortschritt | Commentary

© Georg Thieme Verlag KG Stuttgart · New York

Hepatologie 2007

Hepatology 2007R. Thimme1 , H. C. Spangenberg1 , H. E. Blum1
  • 1Medizinische Universitätsklinik Freiburg
Further Information

Publication History

eingereicht: 15.5.2007

akzeptiert: 16.5.2007

Publication Date:
15 June 2007 (online)

Also available at
    Permissions and Reprints

Was ist neu?

  • Virushepatitis: Entecavir und Tenofovir bei Hepatitis B; Hepatitis-C: Impfung im Tiertest. Individuelle Therapiedauer. Hepatitis-E-Vakzine im Test

  • NASH: Ist Pioglitazon wirksam?

  • Leberzirrhose: Fibro-Scan, Enzephalopathie frühzeitig therapieren. Neue Therapie bei Hyponatriämie?

  • Cholestase: Sertralin bei Pruritus

  • Hepatozelluläres Karzinom: Studien zu medikamentöser Therapie laufen.

  • Transplantation: Neuer Score zur Priorisierung

Literatur

  • 1 Abou-Alfa G K, Schwartz L, Ricci S. et al . Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.  J Clin Oncol. 2006;  24 4293-4300
    Search in Google Scholar
  • 2 Belfort R, Harrison S A, Brown K. et al . A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.  N Engl J Med. 2006;  355 2297-2307
    Search in Google Scholar
  • 3 Berg T, von Wagner M, Nasser S. et al . Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.  Gastroenterology. 2006;  130 1086-1097
    Search in Google Scholar
  • 4 Chang T T, Gish R G, de Man R. et al . A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.  N Engl J Med. 2006;  354 1001-1010
    Search in Google Scholar
  • 5 Chen C J, Yang H I, Su J. et al . Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.  JAMA. 2006;  295 65-73
    Search in Google Scholar
  • 6 Ekstedt M. et al . Long-term follow-up of patients with NAFLD and elevated liver enzymes.  Hepatology. 2006;  44 865-873
    Search in Google Scholar
  • 7 Erhardt A, Lorke J. et al . Transient elastography for diagnosing liver cirrhosis.  Dtsch Med Wochenschr. 2006;  131 2765-1759
    Search in Google Scholar
  • 8 Folgori A, Capone S, Ruggeri L. et al . A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.  Nat Med. 2006;  12 190-197
    Search in Google Scholar
  • 9 Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis.  Hepatology. 2006;  43 1187-1190
    Search in Google Scholar
  • 10 Iloeje U H, Yang H I, Su J. et al . Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.  Gastroenterology. 2006;  130 678-686
    Search in Google Scholar
  • 11 Kamath P S, Kim W R. The model for end-stage liver disease (MELD).  Hepatology. 2007;  45 797-805
    Search in Google Scholar
  • 12 Lai C L, Shouval D, Lok A S. et al . Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.  N Engl J Med. 2006;  354 1011-1020
    Search in Google Scholar
  • 13 Lok A S, McMahon B J. Chronic hepatitis B.  Hepatology. 2007;  45 507-539
    Search in Google Scholar
  • 14 Mayo M J, Handem I, Saldana S. et al . Sertraline as a first-line treatment for cholestatic pruritus.  Hepatology. 2007;  45 666-674
    Search in Google Scholar
  • 15 Ota T, Takamura T, Kurita S. et al . Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.  Gastroenterology. 2007;  132 282-293
    Search in Google Scholar
  • 16 Otto G, Herber S, Heise M. et al . Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.  Liver Transpl. 2006;  12 1260-1267
    Search in Google Scholar
  • 17 Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid.  Gastroenterology. 2006;  130 715-720
    Search in Google Scholar
  • 18 Prasad S, Dhiman R K. et al . Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.  Hepatology. 2007;  45 549-559
    Search in Google Scholar
  • 19 Rapti I, Dimou E et al. Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.  Hepatology. 2007;  45 307-313
    Search in Google Scholar
  • 20 Sarrazin C, Rouzier R, Wagner F. et al . SCH 503 034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders.  Gastroenterology. 2007;  132 1270-1278
    Search in Google Scholar
  • 21 Schrier R W, Gross P, Gheorghiade M. et al . Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.  N Engl J Med. 2006;  355 2099-2112
    Search in Google Scholar
  • 22 Sherman M, Yurdaydin C. et al . Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.  Gastroenterology. 2006;  130 2039-2049
    Search in Google Scholar
  • 23 Shrestha M P, Scott R M. et al . Safety and efficacy of a recombinant hepatitis E vaccine.  N Engl J Med. 2007;  356 895-903
    Search in Google Scholar
  • 24 Sudan D L. Transplantation for cholangiocarcinoma.  Liver Transpl. 2006;  12 S83-84
    Search in Google Scholar
  • 25 van Bommel F, Zollner B, Sarrazin C. et al . Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.  Hepatology. 2006;  44 318-325
    Search in Google Scholar
  • 26 Wedemeyer H, Cornberg M, Wiegand J, Manns M. Treatment duration in acute hepatitis C: the issue is not solved yet.  Hepatology. 2006;  44 1051
    Search in Google Scholar
  • 27 Zeuzem S, Buti M, Ferenci P. et al . Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.  J Hepatol. 2006;  44 97-103
    Search in Google Scholar
  • 28 Kettaneh A, Marcellin P, Douvin C. et al . Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients.  J Hepatol. 2007;  46 628-634
    Search in Google Scholar

Professor Dr. med. Robert Thimme

Medizinische Universitätsklinik Freiburg

Hugstetter Straße 55

79106 Freiburg

Phone: 0761/270-3401

Fax: 0761/270-3372

Email: robert.thimme@uniklinik-freiburg.de